Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Melba Massie

Physician Assistant Ashland, KY Physician Assistant

NPI 1235161902 CMS profile 11138247

1000 Ashland Dr Ste 103, Ashland, KY 41101

Open in the dashboard

General payments

$828

92 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Melba Massie of Ashland, KY is reported in the CMS Open Payments database as having received $828 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $47 3
2023 General $18 1
2022 General $323 34
2021 General $440 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Melba Massie
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Melba Massie were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Melba Massie Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $440 $132 $37–$438 $132
2022 $323 $155 $48–$522 $149
2023 $18 $167 $52–$557 $160
2024 $47 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Janssen Pharmaceuticals, Inc $400 51 payments
  2. AbbVie, Inc. $285 29 payments
  3. Novo Nordisk Inc $39 3 payments
  4. GlaxoSmithKline, LLC. $28 2 payments
  5. Lilly USA, LLC $16 1 payment
  6. Biohaven Pharmaceutical Holding Company Ltd. $15 1 payment
  7. AstraZeneca Pharmaceuticals LP $14 1 payment
  8. Novartis Pharmaceuticals Corporation $13 1 payment
  9. Merck Sharp & Dohme Corporation $12 1 payment
  10. Genentech USA, Inc. $5 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $828 92 payments
Products named General payments · program years 2021–2024
  1. XARELTO $400 51 payments
  2. VRAYLAR $232 23 payments
  3. UBRELVY $53 6 payments
  4. RYBELSUS $39 3 payments
  5. Ozempic $24 2 payments
  6. QULIPTA $18 1 payment
  7. JARDIANCE $16 1 payment
  8. TRULICITY $16 1 payment
  9. ANORO ELLIPTA $16 1 payment
  10. NURTEC ODT $15 1 payment
  11. Other $105 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 84 drugs

Part D claims

2,665

Median for Physician Assistant: 241

Drug cost

$254,553

Median for Physician Assistant: $4,110

Branded share of claims

23.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 53 $47,836
Eliquis Apixaban Brand 20 $27,170
Ozempic Semaglutide Brand 20 $26,421
Breo Ellipta Fluticasone/Vilanterol Brand 59 $24,101
Mounjaro Tirzepatide Brand 21 $24,035
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 27 $19,826
Farxiga Dapagliflozin Propanediol Brand 11 $15,455
Spiriva Handihaler Tiotropium Bromide Brand 12 $9,016
Advair Hfa Fluticasone Propion/Salmeterol Brand 14 $7,582
Myrbetriq Mirabegron Brand 13 $7,024

The 10 drugs with the highest cost, of 84 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$17,698

Medicare's payments for the services billed

Medicare patients

53

Average age 70

Services billed

406

35 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Diabetes 43%
Chronic kidney disease 32%
Depression 32%
COPD 26%
Ischemic heart disease 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $28
$28 — —
UBRELVY
  • AbbVie, Inc. $9
$9 — —
QULIPTA
  • AbbVie, Inc. $9
$9 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record